Finance

Beta
Lists
002675:SHE
Yantai Dongcheng Biochemicals Co Ltd
CNÂ¥12.55
-0.16%
(-0.020) 1D
Jun 5, 3:04:48 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002675...
Open
CNÂ¥12.63
High
CNÂ¥12.77
Low
CNÂ¥12.52
Mkt. cap
10.35B
Avg. vol.
10.39M
Volume
7.48M
Dividend
0.64%
Quarterly dividend
CNÂ¥0.02
Ex-dividend date
Apr 29, 2026
P/E ratio
50.65
52-wk high
CNÂ¥18.68
52-wk low
CNÂ¥12.12
EPS
CNÂ¥0.25
Shares outstanding
824.60M
No. of employees
3K
Open
CNÂ¥12.63
High
CNÂ¥12.77
Low
CNÂ¥12.52
Mkt. cap
10.35B
Avg. vol.
10.39M
Volume
7.48M
Dividend
0.64%
Quarterly dividend
CNÂ¥0.02
Ex-dividend date
Apr 29, 2026
P/E ratio
50.65
52-wk high
CNÂ¥18.68
52-wk low
CNÂ¥12.12
EPS
CNÂ¥0.25
Shares outstanding
824.60M
No. of employees
3K
News stories
From sources across the web
About Yantai Dongcheng Biochemicals Co Ltd
CEO-
Employees2.58K
FoundedDec 31, 1998
Headquarters-
SectorBiotechnology
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
696.78M
659.38M
697.99M
626.37M
Cost of goods sold
366.27M
274.54M
339.95M
293.57M
Cost of revenue
366.27M
274.54M
339.95M
293.57M
Research and development expenses
50.74M
67.59M
70.28M
42.01M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
173.54M
201.78M
183.72M
189.42M
Operating expense
221.35M
264.21M
289.10M
243.65M
Total operating expenses
587.63M
538.75M
629.04M
537.22M
Operating income
109.16M
120.63M
68.94M
89.15M
Other non operating income
-3.70M
-1.14M
171.66K
-7.23M
EBT including unusual items
77.24M
69.58M
29.78M
48.41M
EBT excluding unusual items
79.75M
82.22M
13.30M
48.18M
Income tax expense
24.35M
15.06M
-108.90K
13.54M
Effective tax rate
31.52%
21.65%
-0.37%
27.97%
Other operating expenses
10.71M
-6.50M
28.66M
4.10M
Net income
63.92M
60.46M
46.51M
33.44M
Net profit margin
9.17%
9.17%
6.66%
5.34%
Earnings per share
0.08
0.06
0.06
0.04
Interest and investment income
1.21M
1.83M
1.19M
2.75M
Interest expense
-29.80M
-36.22M
-43.78M
-36.48M
Net interest expenses
-28.59M
-34.39M
-42.59M
-33.74M
Depreciation and amortization charges
-
-
-
-
EBITDA
152.83M
158.15M
113.56M
133.77M
Gain or loss from assets sale
-194.23K
194.23K
-82.38K
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more